Dr. Chatta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3519
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1996- University of WashingtonFellowship, Geriatric Medicine (Internal Medicine), 1988 - 1992
Aurora Health CareResidency, Internal Medicine, 1986 - 1988
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1985 - 1985
Delhi University College of Medical SciencesClass of 1979
Certifications & Licensure
NY State Medical License 2016 - 2025
WA State Medical License 1988 - 2025
AK State Medical License 2015 - 2024
PA State Medical License 2001 - 2024
AR State Medical License 1997 - 2001
WI State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer Start of enrollment: 2022 Jan 26
Roles: Principal Investigator, Contact
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery Start of enrollment: 2019 Nov 29
Roles: Contact, Principal Investigator
- Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors Start of enrollment: 2019 May 02
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsAndrogen receptor (AR) heterogeneity in prostate cancer and therapy resistance.Anmbreen Jamroze, Gurkamal Chatta, Dean G. Tang
Cancer Letters. 2021-06-09 - 25 citationsAdjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.Sherrie L Aspinall, Chester B Good, Xinhua Zhao, Francesca E Cunningham, Bernadette B Heron
BMC Cancer. 2015-02-18 - 84 citationsT-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitorsTakayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen
Nature Communications. 2021-03-03
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
